EUVIMEDEUVIMED entdecken
Übersichtsarbeit

A fresh start for IVM: capacitating the oocyte for development using pre-IVM

Robert B Gilchrist iD, Tuong M Ho, Michel De Vos iD, Flor Sanchez, Sergio Romero, William L Ledger, Ellen Anckaert, Lan N Vuong, Johan Smitz

Human Reproduction Update · 03.01.2024 · 30 (1) · 3-25

DOI: 10.1093/humupd/dmad023 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Human Reproduction Update, online erschienen am 28.08.2023. Verfasst von Robert B Gilchrist und 8 weiteren Autor:innen. Beteiligte Einrichtung: Fertility & Research Centre, Discipline of Women's Health, School of Clinical Medicine, University of New South Wales Sydney, NSW, Australia. Hauptthemen laut MEDLINE: In Vitro Oocyte Maturation Techniques, Polycystic Ovary Syndrome. Die Arbeit wurde bisher 84-mal zitiert (Crossref) und nennt 197 Literaturangaben. Gefördert von: Investigator Fellowship, National Health and Medical Research Council of Australia, Open Philanthropy.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND While oocyte IVM is practiced sporadically it has not achieved widespread clinical practice globally. However, recently there have been some seminal advances in our understanding of basic aspects of oocyte biology and ovulation from animal studies that have led to novel approaches to IVM. A significant recent advance in IVM technology is the use of biphasic IVM approaches. These involve the collection of immature oocytes from small antral follicles from minimally stimulated patients/animals (without hCG-priming) and an ∼24 h pre-culture of oocytes in an advanced culture system (‘pre-IVM’) prior to IVM, followed by routine IVF procedures. If safe and efficacious, this novel procedure may stand to make a significant impact on human ART practices. OBJECTIVE AND RATIONALE The objectives of this review are to examine the major scientific advances in ovarian biology with a unique focus on the development of pre-IVM methodologies, to provide an insight into biphasic IVM procedures, and to report on outcomes from animal and clinical human data, including safety data. The potential future impact of biphasic IVM on ART practice is discussed. SEARCH METHODS Peer review original and review articles were selected from PubMed and Web of Science searches for this narrative review. Searches were performed using the following keywords: oocyte IVM, pre-IVM, biphasic IVM, CAPA-IVM, hCG-triggered/primed IVM, natural cycle IVF/M, ex-vivo IVM, OTO-IVM, oocyte maturation, meiotic competence, oocyte developmental competence, oocyte capacitation, follicle size, cumulus cell (CC), granulosa cell, COC, gap-junction communication, trans-zonal process, cAMP and IVM, cGMP and IVM, CNP and IVM, EGF-like peptide and IVM, minimal stimulation ART, PCOS. OUTCOMES Minimizing gonadotrophin use means IVM oocytes will be collected from small antral (pre-dominant) follicles containing oocytes that are still developing. Standard IVM yields suboptimal clinical outcomes using such oocytes, whereas pre-IVM aims to continue the oocyte’s development ex vivo, prior to IVM. Pre-IVM achieves this by eliciting profound cellular changes in the oocyte’s CCs, which continue to meet the oocyte’s developmental needs during the pre-IVM phase. The literature contains 25 years of animal research on various pre-IVM and biphasic IVM procedures, which serves as a large knowledge base for new approaches to human IVM. A pre-IVM procedure based on c-type natriuretic peptide (named ‘capacitation-IVM’ (CAPA-IVM)) has undergone pre-clinical human safety and efficacy trials and its adoption into clinical practice resulted in healthy live birth rates not different from conventional IVF. WIDER IMPLICATIONS Over many decades, improvements in clinical IVM have been gradual and incremental but there has likely been a turning of the tide in the past few years, with landmark discoveries in animal oocyte biology finally making their way into clinical practice leading to improved outcomes for patients. Demonstration of favorable clinical results with CAPA-IVM, as the first clinically tested biphasic IVM system, has led to renewed interest in IVM as an alternative, low-intervention, low-cost, safe, patient-friendly ART approach, and especially for patients with PCOS. The same new approach is being used as part of fertility preservation in patients with cancer and holds promise for social oocyte freezing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

In Vitro Oocyte Maturation TechniquesPolycystic Ovary SyndromeAnimalsFemaleHumansOocytesOogenesisOvarian Follicle

Stichwörter der Autor:innen

IVMbiphasic IVMcapacitation IVMminimal stimulationoocyte developmental competencepre-maturation

Autor:innen und Institutionen

  • Fertility & Research Centre, Discipline of Women's Health, School of Clinical Medicine, University of New South Wales Sydney, NSW, Australia.
  • IVFMD, My Duc Hospital, Ho Chi Minh City, Vietnam.
  • Brussels IVF, UZ Brussel, Brussels, Belgium.
  • Follicle Biology Laboratory, UZ Brussel, Vrije Universiteit Brussel, Brussels, Belgium.
  • Centro de Estudios e Investigaciones en Biología y Medicina Reproductiva, Lima, Peru.
  • Laboratory of Reproductive Biology and Fertility Preservation, Cayetano Heredia University (UPCH), Lima, Peru.

ORCID-Profile: Robert B Gilchrist, Michel De Vos

Förderung

  • Investigator Fellowship
  • National Health and Medical Research Council of Australia
  • Open Philanthropy
  • Vietnam National Foundation for Science and Technology Development (NAFOSTED)
  • Fonds voor Wetenschappelijk Onderzoek Vlaanderen
  • Excellence of Science (EOS) FWO-FNRS (National Fund for Scientific Research)
  • Foundation Against Cancer
  • IVM

Zitieren

APA

Gilchrist, R. B., Ho, T. M., De Vos, M., Sanchez, F., Romero, S., Ledger, W. L., Anckaert, E., Vuong, L. N., & Smitz, J. (2024). A fresh start for IVM: capacitating the oocyte for development using pre-IVM. Human Reproduction Update, 30(1), 3-25. https://doi.org/10.1093/humupd/dmad023

Vancouver

Gilchrist RB, Ho TM, De Vos M, Sanchez F, Romero S, Ledger WL, et al. A fresh start for IVM: capacitating the oocyte for development using pre-IVM. Human Reproduction Update. 2024;30(1):3-25. doi:10.1093/humupd/dmad023

BibTeX
@article{Gilchrist2024,
  author = {Gilchrist, Robert B and Ho, Tuong M and De Vos, Michel and Sanchez, Flor and Romero, Sergio and Ledger, William L and Anckaert, Ellen and Vuong, Lan N and Smitz, Johan},
  title = {A fresh start for IVM: capacitating the oocyte for development using pre-IVM},
  journal = {Human Reproduction Update},
  year = {2024},
  volume = {30},
  number = {1},
  pages = {3--25},
  doi = {10.1093/humupd/dmad023}
}
Kostenlos starten →